SRY and hepatocellular carcinoma: However, since female transgenic mice showed lower HCC occurrence than male transgenic mice (55.6% vs. 100%), it seems likely that there is an influence of other gender-related factors (e.g., estrogen) on the promotion of hepatocarcinogenesis induced through SRY activation.